Study guide
9.2 EQUIP Image-Quality Criteria
ARRT Mammography Postprimary
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Postprimary Eligibility, Structured Education, and Clinical Requirements 1.3 Scoring, Retakes, Fees, and Credential Maintenance 1.4 2025 Content Outline, Domain Weights, and Study Strategy
2 Patient Communication
2.1 Pre-Exam Instructions 2.2 Explaining the Exam, Rapport, and Support 2.3 Patient Education: ACS/ACR Guidelines, BSE, CBE, Dose, and Modalities
3 Results Communication and Breast Cancer Risk
3.1 Process for Receiving Results and Additional Imaging 3.2 Epidemiology and Inherent Risk Factors 3.3 Social Risk Factors, Access, and Hormone Use 3.4 Signs and Symptoms of Breast Disease
4 History, Priors, and Treatment Context
4.1 Medical History, Physical Findings, and Gender Affirmation 4.2 Previous Mammograms 4.3 Surgical, Nonsurgical, and Reconstruction Options
5 Mammography Unit Design
5.1 kVp Range, Tube, Filtration, Window, and Focal Spot 5.2 Compression Paddles, Grids, and System Geometry
6 Digital Acquisition, Display, and Informatics
6.1 FFDM-DR/2D, DBT/3D, and Synthesized Imaging 6.2 Image Receptors and Acquisition vs Interpretation Monitors 6.3 HIS/RIS/EMR, PACS, and CAD
7 Accreditation, MQSA, EQUIP, and Density Reporting
7.1 Accreditation Bodies, FDA/MQSA Personnel, Records, Audits, and Policies 7.2 EQUIP: QA Oversight, Clinical Image Quality, and Corrective Action 7.3 Breast Density Reporting Requirements
8 Quality Control Testing
8.1 Mammographer QC: Phantom Image, Compression Thickness, Visual Checklist 8.2 Mammographer QC: Monitors, Repeat Analysis, Viewing Conditions, Compression Force, Detector Calibration 8.3 Physicist Tests: MEE, Collimation, Spatial Resolution/MTF, SNR/CNR, AEC, AGD, kVp, HVL 8.4 Physicist Tests: Artifacts, Phantom Quality, Illuminance, Tech QC Program Review, Compression Application/Paddle Alignment, Workstation QC
9 Technique and Image Evaluation
9.1 Technical Factors: kVp, mAs, AEC vs Manual, Target/Filter, Focal Spot, Grid, Mag, Labeling 9.2 EQUIP Image-Quality Criteria 9.3 Patient-Related Artifacts
10 Localization and Anatomy
10.1 Clock Position, Quadrants, and Triangulation 10.2 External Anatomy 10.3 Internal Anatomy: Fascia, Glandular Tissue, and the TDLU 10.4 Cooper Ligaments, Pectoral Muscle, Vascular/Lymphatic Systems, and Cytology
11 BI-RADS Lexicon
11.1 Architectural Distortion, Asymmetry, and Mass Features 11.2 Calcification Morphology and Distribution 11.3 Assessment Categories, Breast Density, and Recommendations
12 Breast Pathology
12.1 Benign Pathology and Mammographic Appearance 12.2 Lesions with Upgrade Potential 12.3 DCIS, IDC, and Invasive Lobular Carcinoma 12.4 Inflammatory Carcinoma, Paget Disease, Sarcoma, Lymphoma, and Metastases
13 Standard Screening Views
13.1 Craniocaudal (CC) Positioning 13.2 Mediolateral Oblique (MLO) Positioning
14 Additional Views I
14.1 Mediolateral (ML) and Lateromedial (LM) 14.2 XCCL, XCCM, Cleavage (CV), and Axillary Tail (AT) 14.3 Tangential (TAN) and Rolled Views (RL, RM, RS, RI)
15 Additional Views II
15.1 Implant Displaced (ID), Nipple in Profile, and Anterior Compression 15.2 Spot Compression and Magnification
16 Patient Variance
16.1 Chest Wall Variations, Kyphosis/Lordosis, Protruding Abdomen, and Extreme Breast Size 16.2 Irradiated Breast, Reduction Mammoplasty, and Postsurgical Breast 16.3 Male Patients and Lactating Breast 16.4 Breast Augmentation and Implanted Devices
17 Imaging Examinations
17.1 Screening vs Diagnostic Mammography 17.2 Breast Ultrasound and Breast MRI
18 Interventional Procedures
18.1 History, Consent, Time-Out, Setup, and Postprocedure Instructions 18.2 Stereotactic and Ultrasound-Guided Biopsy 18.3 Needle Localization, Specimen Imaging, and Clip Placement 18.4 Handling and Disposing of Biohazardous Materials
9.2 EQUIP Image-Quality Criteria
Key Takeaways Explain This Topic AI
EQUIP clinical image criteria match the eight ACR attributes in 21 CFR 900.4(c)(2): positioning, compression, exposure, contrast, sharpness, noise, artifacts, and examination identification.
Digital underexposure shows as quantum noise, not a light film; motion unsharpness is patient movement during a long exposure, while geometric unsharpness is a focal-spot or object-to-image-distance error.
Inadequate compression causes overlapping tissue, motion, and non-uniform exposure that monitor windowing cannot repair.
Repeat correctable technical fails before the patient leaves; accept and document true physical limitations; mark skin lesions rather than pretending they are technique errors.
The interpreting physician determines poor quality for ongoing EQUIP feedback; the lead interpreting physician is accountable for continuous image quality without turning the AWS check into a full inspection-policy review.
Last updated: August 2026
The September 1, 2025 ARRT Mammography content specifications placed EQUIP under mammographic technique and image evaluation. This section is not the full inspection-policy chapter. It is what “adequate” looks like on the AWS so you can decide repeat , accept , or mark and document before the lead interpreting physician ( LIP ) ever sees a poor image in a periodic sample.
The Food and Drug Administration’s Enhancing Quality Using the Inspection Program asks whether clinical images continue to meet the facility’s accreditation-body standards. Those standards are the eight attributes in 21 CFR 900.4(c)(2)—the same list the American College of Radiology ( ACR ) uses for clinical image review: positioning, compression, exposure level, contrast, sharpness, noise, artifacts, and examination identification . The attributes apply to screen-film, FFDM, and DBT. A pretty tomosynthesis cine does not excuse a noisy, motion-blurred acquisition.
Positioning at EQUIP / AWS Level
You are not repeating the entire positioning atlas here. “Adequate” means the image includes the tissue the view is meant to show, without extra body parts replacing breast:
CC: medial tissue on the receptor, posterior nipple line ( PNL ) within about 1 cm of the MLO PNL, nipple in profile when possible.
MLO: pectoralis muscle convex or straight, extending to or below the PNL; inframammary fold ( IMF ) open; posterior tissue included.
Missing chest wall, a folded IMF, or abdomen occupying the posterior third is a technical repeat if the patient can be repositioned. Documented limitations (wheelchair, pectus, frozen shoulder) may be accepted with a note . That is not permission to release a sloppy image from an able patient.
Tight collimation belongs with scatter control: cone to calcifications on mag views; do not crop posterior tissue on a screening CC just to make the histogram look pretty.
Compression
Adequate compression thins the breast uniformly, reduces scatter and dose, and immobilizes tissue. Inadequate compression looks like:
- Overlapping fibroglandular tissue that cannot be “windowed away”
- Motion blur on one view
- Non-uniform exposure (thin anterior tissue punched out, thick posterior tissue noisy)
- Skin folds pulled into the field because the breast was not lifted taut
If overlap or motion is from under-compression and the patient can tolerate more, repeat . If pain or a hard implant capsule stopped you at a documented limit, mark and document rather than grinding the patient for a number on the readout. EQUIP cares that poor compression is recognized; it does not require you to injure the patient.
Exposure on Digital Images
Forget “too light / too dark” as the primary digital cue.
Underexposure: grainy, especially in dense regions; calcifications and spiculations sink into noise. Check displayed mAs and any vendor exposure index. Repeating with more photons—or a more appropriate kVp so AEC can finish—is indicated.
Overexposure: the processed image may still look fine. Clues are an outlier mAs for that thickness, a clipped skin line, or implant/hardware that sat on the AEC cell. Repeat with manual technique or a repositioned sensor; do not “fix it” only by brightening the monitor.
If you would have called a film too light, look for noise on digital. If you would have called a film too dark, look at dose and AEC logic, not only at the pretty grayscale.
Contrast
Adequate contrast means fat and glandular tissue are distinguishable and dense regions are penetrated enough to see through, not merely outlined. Causes of poor contrast include too-high kVp, grid left out on a contact view, scatter from a huge uncollimated field, and under-compression. Digital windowing can mask a mild miss; it cannot restore subject contrast that never reached the detector. If the whole breast is a homogeneous gray after reasonable windowing, change technique and repeat.
Sharpness: Motion Unsharpness Versus Geometric Unsharpness
Sharpness is the EQUIP attribute that fails microcalcifications and spiculated margins. Two operator-controlled blurs look similar until you take a history.
Motion unsharpness is patient or breast movement during a long exposure. It smears trabeculae, skin, and calcifications, often along one direction, and is more common on MLO (arm fatigue, breathing, longer time). Fix: more effective immobilization, shorter time (higher kVp or harder filter), clearer breath-hold coaching, then repeat .
Geometric unsharpness is physics: large focal spot, large object-to-image distance, or magnification with the wrong spot. The blur is not from the patient wiggling. Fix: small spot on the mag platform, breast as close to the receptor as the view allows on contact, no accidental OID from a mag stand left in place.
Repeating without changing geometry will not fix a large-spot mag view. Coaching stillness will not fix a contact-size spot used at 1.8× magnification. Screen-film also had screen-film contact blur; on FFDM the operator-controlled sharpness fails remain motion and geometry.
Noise and Artifacts
Noise on digital mammography is usually quantum mottle from underexposure. It is grain that hides low-contrast masses. EQUIP scores noise separately from artifacts.
Artifacts include anything that is not anatomy and not quantum noise: deodorant specks, hair, clothing, skin folds, grid lines, detector ghosts. Patient-related artifacts are the next section. At EQUIP level, decide whether the artifact overlays tissue that must be interpreted . If yes and it is removable, repeat. If it is a pacemaker generator, it is not a “repeat until gone” problem.
Examination Identification
This is the MQSA label set from 21 CFR 900.12(c)(5), scored as an image-quality attribute. Missing laterality, a view code not near the axilla, or the wrong patient identifier is a correct-and-rerelease problem. It is not optional “nice to have” data. ACR clinical image review still grades labeling; EQUIP uses the same attribute.
Repeat Versus Accept Versus Mark and Document
Finding on the AWS Action Why
Motion blur, removable artifact over parenchyma, under-compression in a cooperative patient, AEC fail, wrong mag/focal-spot/grid bundle, missing MQSA ID Repeat (or correct labels) before the patient leaves Technical and correctable; EQUIP expects poor images not to be handed to the IP as if they were fine
Documented physical limit (severe kyphosis, pain stop, pectus) with best achievable tissue Accept and document the limitation The IP and LIP need the limitation stated; repeating the same geometry will not create tissue that is not there
Skin lesion, scar, or mole that could mimic a mass or calcifications Mark (BB/mole marker) and document; repeat only if the marker itself hides tissue Marks prevent false-positive work-ups; they are not a substitute for wiping deodorant
Classic intramammary node, stable implant, pacemaker at the edge of the MLO Leave for the radiologist ; do not “repeat to remove anatomy” Not a technical fail
The interpreting physician (IP) —not the inspector—decides whether an image is of poor quality for EQUIP corrective-action purposes and must have a way to give ongoing feedback to technologists. The LIP is the MQSA-designated physician most responsible for continuous image quality and for including a sample of images each IP (including the LIP) accepted. Your job at the AWS is to keep obviously inadequate images out of that pile.
Daily interpretation of every case is not the same as the facility’s periodic EQUIP sample review, and repeat-analysis QC is not a substitute for clinical-image review. Those distinctions belong in the policy chapter. What belongs here: if you would be embarrassed to submit the image for ACR clinical image review, do not send it as a finished mammogram.